Papers: 10.1371/journal.pone.0247941

https://doi.org/10.1371/journal.pone.0247941

Immunoglobulin Replacement Therapy is critical and cost-effective in increasing life expectancy and quality of life in patients suffering from Common Variable Immunodeficiency Disorders (CVID): A health-economic assessment

Cited by: 4
Author(s): Philippe Van Wilder, Irina Odnoletkova, Mehdi Mouline, Esther de Vries
Published: over 5 years ago

Software Mentions 1